[Gaucher's disease with D409H/D409H genotype. evolution with enzyme replacement therapy]

An Esp Pediatr. 2001 Mar;54(3):310-2.
[Article in Spanish]

Abstract

Gaucher's disease is caused by mutations in the gene encoding glucocerebrosidase. The D409H mutation is the third most frequent mutation in Spain and has been associated with a particular phenotype, including oculomotor apraxia and cardiac valvular calcifications in late childhood. We report a 4-year-old patient, homozygous for the D409H mutation, who was diagnosed with Gaucher's disease at the age of 45days. Enzyme replacement therapy was started at the age of 2months. We report the patient's evolution after 4years of treatment.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Child, Preschool
  • Gaucher Disease / drug therapy*
  • Gaucher Disease / genetics*
  • Genotype
  • Glucosylceramidase / therapeutic use*
  • Humans
  • Infant
  • Male
  • Spain

Substances

  • Glucosylceramidase